D-1501-2016 Class III Terminated

Recalled by Amerisource Health Services — Columbus, OH

FDA drug recall D-1501-2016 was initiated by Amerisource Health Services on Aug 4, 2016 and is designated Class III. Reason for recall: Failed dissolution specifications - the out of specification result for dissolution was identified during 3 month stability testing. The recall status is terminated (terminated Jul 17, 2017). Affected quantity: 2626 bottles.

Recall details

Product Type
Drugs
Report Date
Sep 21, 2016
Initiation Date
Aug 4, 2016
Termination Date
Jul 17, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
2626 bottles

Product description

buPROPion Hydrochloride Extended-Release Tablets, USP (XL), 300mg, 500-count bottle, Rx only, Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India For BluePoint Laboratories, NDC 68001-264-03

Reason for recall

Failed dissolution specifications - the out of specification result for dissolution was identified during 3 month stability testing.

Distribution pattern

Nationwide and Puerto Rico

Code information

Lot #: MS1509, Exp 12/17

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1501-2016
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1501-2016. Report a data issue: hello@regdatalab.com.